Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vanguard Dividend Appreciation Index Fund ETF Shares (VIG)

Delayed Data
As of Dec 13
 +0.16 / +0.16%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the performance of a benchmark index that measures the investment return of common stocks of companies that have a record of increasing dividends over time. The fund employs an indexing investment approach designed to track the performance of the NASDAQ US Dividend Achievers Select Index- which consists of common stocks of companies that have a record of increasing dividends over time. The adviser attempts to replicate the target index by investing all- or substantially all- of its assets in the stocks that make up the index- holding each stock in approximately the same proportion as its weighting in the index.

No recent news for Vanguard Dividend Appreciation Index Fund ETF Shares.


1 month+4.19% 3 years+11.01%
3 months+8.32% 5 years+13.54%
1 year+18.82% Since inception+8.47%
Data through 12/14/2017

Quote Details

Previous close$101.25
Open day’s range101.26 – 101.70
Net asset value (NAV)101.38 (12/13/2017)
Daily volume476,387
Average volume (3 months)501,268
Data as of 8:00pm ET, 12/13/2017

Peer Comparisonvs. Large blend ETFs

Performance 5-yr return+13.54%+12.91%
Expense Gross exp ratio0.08%0.98%
Risk 5 year sharpe ratio1.381.37
Net assets$33.5B$5.3B
Average market cap$49.3B$132.8B
Average P/E23.322.2
Dividend / Share--0.19%


VOO Vanguard S&P 500 ETF
IVV iShares Core S&P 500 ETF
MGC Vanguard Mega Cap Index Fund ETF Shares


Top 5 Sectors
Portfolio weighting
Industrial materials 22.52%
Consumer goods 19.17%
Consumer service 17.54%
Healthcare 12.63%
Energy 11.14%
Top 10 Holdings
Portfolio weighting
MSFT Microsoft4.84%
JNJ Johnson & Johnson4.24%
PEP Pepsi3.72%
MMM 3M3.67%
MDT Medtronic PLC2.96%
TXN Texas Instruments2.58%
UTX United Technologies2.58%
UNP Union Pacific2.52%
ACN Accenture2.51%
ABT Abbott Laboratories2.51%